| Market Cap | ₹3,513.67 CrSmall Cap |
|---|---|
| Revenue TTM | ₹4,223.79 CrOperating Revenue |
| Operating Margin | 15.48%Quarterly |
| RSI | 40.78Neutral Zone |
Key highlights
- Commercial production officially started at Phase III of Multi-Purpose Production Block III
- Facility is located at the Custom Manufactured Chemicals Division in Berigai
- The production commencement was recorded at 5:38 PM IST on May 28, 2026
- This milestone completes the planned Phase III expansion for this specific production unit
- Expansion focuses on enhancing capacity for high-value specialty chemical intermediates
Production Commenced — What It Means
Chemplast Sanmar has formally operationalized Phase III of its Multi-Purpose Production Block III, situated within the Custom Manufactured Chemicals Division at Berigai. This commencement signifies the successful transition from construction and testing to active commercial output. By reaching this milestone, the company expands its manufacturing footprint in the specialty chemicals segment, specifically targeting complex chemical synthesis.
The additional capacity is designed to meet the growing requirements of global innovators who rely on outsourced manufacturing for critical chemical intermediates used in diverse industrial applications.
Revenue Impact
The activation of this new production block is strategically positioned to bolster the financial performance of the Custom Manufactured Chemicals Division. While the company recorded a TTM revenue of 4,223.79 crore, it has faced profitability pressures with a net loss reported in recent periods. The shift toward higher-margin specialty products through the Berigai facility is a move to improve consolidated margins, which stood at 15.48% in the latest quarter.
This capacity ramp-up allows for better absorption of fixed costs and provides the infrastructure necessary to scale contract manufacturing volumes.
Business Overview
- Major Indian manufacturer of Specialty Paste PVC, Caustic Soda, and Chloromethanes
- Operates a dedicated Custom Manufactured Chemicals Division focusing on global contract research and manufacturing
- The Berigai facility serves as a core hub for complex chemical synthesis and process development
- Strategic focus on diversifying away from commodity chemicals toward value-added specialty segments
- Maintains a strong relationship with international pharmaceutical and agrochemical innovators
Sector Tailwinds
The Indian specialty chemicals industry continues to benefit from the global supply chain diversification strategy, often referred to as China Plus One. Global companies are increasingly seeking reliable manufacturing partners in India for high-quality chemical intermediates. Chemplast Sanmar's investment in multi-purpose blocks provides the flexibility to manufacture a wide variety of products based on fluctuating market demands.
This agility is crucial in the specialty segment, where short product lifecycles and specific technical requirements demand modular and scalable production environments.
| Share price | ₹222.23 |
|---|---|
| Market capitalisation | ₹3,513.67 Cr |
| Revenue (annual) | ₹4,223.79 Cr |
| Net profit (annual) | -₹279.87 Cr |
| Revenue (latest quarter) | ₹1,255.55 Cr+50.34% vs previous quarter |
| Net profit (latest quarter) | -₹45.38 Cr+61.93% vs previous quarter |
| P/E (TTM) | -12.55×Sector 42.35× |
| Promoter holding | 54.99%0.00% QoQ |
| FII holding | 12.48%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Chemplast Sanmar Limited announcing the commencement of commercial production at its Berigai facility. Market figures from a third-party data provider.
